Uterine Carcinosarcomas: Clinical, Histopathologic and Immunohistochemical Characteristics
Authors:
- Rebecca ArendRARebecca Arend
- Diane Hamele-BenaDHDiane Hamele-Bena
- Ana I. TergasATAna I. Tergas
- Melanie HawverMHMelanie Hawver
- Guo-Xia TongGTGuo-Xia Tong
- Thomas C. WrightTWThomas C. Wright
- Jason D. WrightJWJason D. Wright
- 1 September 2017
- journal article
- research article
- Published by Wolters Kluwer Health in International Journal of Gynecological Pathology
- Vol. 36 (5) , 412-419
Abstract
Carcinosarcomas (malignant mixed Müllerian tumors or MMMT) are rare malignant tumors in the female genital tract composed of both malignant epithelial and malignant mesenchymal components. They comprise <5% of all neoplasms in the gynecologic tract and have an aggressive clinical course. The purpose of this study is to evaluate the immunophenotype and possible histogenesis of carcinosarcomas of the uterus. Sixty-two cases of uterine carcinosarcomas diagnosed between 1995 and 2011 were retrieved from the gynecologic pathology files at Columbia University Medical Center. Representative tissue blocks containing both epithelial and mesenchymal components were selected from each case for histologic and immunohistochemical studies. Clinical data from each case were retrieved. The epithelial component was poorly differentiated adenocarcinoma in the majority (80.7%) of cases; in 17.7%, the carcinoma was moderately differentiated, and in only 1.6% the carcinoma was well differentiated. 53% of the tumors had homologous stromal elements and 47% displayed heterologous stromal elements. Immunohistochemical study revealed almost equal staining in both epithelial and mesenchymal components of carcinosarcomas for p16 and p53. PAX8 positivity was noted in 73% of epithelial components, but only 13% of stromal components, and PAX8 stromal positivity was never seen in the absence of PAX8 epithelial positivity. Expression of p16, p53, and PAX8 in both malignant components lends support to the monoclonal theory of uterine carcinosarcoma tumorigenesis. The roles of these tumor markers in the diagnosis and pathogenesis of this tumor and associations between clinical characteristics, tumor pathologic features, and prognosis are discussed.Keywords
This publication has 28 references indexed in Scilit:
- Pax‐8 is a reliable marker in making the diagnosis in advanced stage epithelial ovarian carcinoma and primary peritoneal carcinoma for neoadjuvant chemotherapy on cell block and biopsy specimensHistopathology, 2012
- Pax8: A marker for carcinoma of Müllerian origin in serous effusionsDiagnostic Cytopathology, 2011
- Comparative Analysis of P16 and P53 Expression in Uterine Malignant Mixed Mullerian TumorsInternational Journal of Gynecological Pathology, 2009
- Utility of p16 Expression for Distinction of Uterine Serous Carcinomas From Endometrial Endometrioid and Endocervical AdenocarcinomasAmerican Journal of Surgical Pathology, 2009
- Prognostic Features of Surgical Stage I Uterine CarcinosarcomaAmerican Journal of Surgical Pathology, 2007
- Immunohistochemical Overexpression of p16 and p53 in Uterine Serous Carcinoma and Ovarian High-grade Serous CarcinomaInternational Journal of Gynecological Pathology, 2007
- DNA mismatch repair and TP53 defects are early events in uterine carcinosarcoma tumorigenesisLaboratory Investigation, 2006
- Immunophenotypic diversity of endometrial adenocarcinomas: implications for differential diagnosisLaboratory Investigation, 2006
- p16 INK4A Alterations are accompanied by aberrant protein immunostaining in endometrial carcinomasJournal of Cancer Research and Clinical Oncology, 2003
- Uterine carcinosarcomas (malignant mixed Mullerian tumors) are metaplastic carcinomasInternational Journal of Gynecological Cancer, 2002